Cargando…

Identification of Locally Advanced Rectal Cancer with Low Risk of Local Recurrence

BACKGROUND: The routine application of neoadjuvant chemoradiotherapy for T3N0 rectal cancer remains controversial. The aim of this study was to use clinical, Magnetic resonance imaging, and pathological parameters to identify a subgroup of patients with low risk of local recurrence who might be prec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiao-Xuan, Li, Shao-Hua, Zhang, Xu, Xie, Lan, Cai, Pei-Qiang, An, Xin, Pan, Zhi-Zhong, Ding, Pei-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309455/ https://www.ncbi.nlm.nih.gov/pubmed/25629521 http://dx.doi.org/10.1371/journal.pone.0117141

Ejemplares similares

The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Liu, Guo-Chen, et al.
Publicado: (2015)

Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis
por: Liu, Guo-Chen, et al.
Publicado: (2016)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer
por: Zhang, Lu-Ning, et al.
Publicado: (2016)

The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
por: Tang, Jing-Hua, et al.
Publicado: (2015)

Strategy to avoid local recurrence in patients with locally advanced rectal cancer
por: Nakamura, Takatoshi, et al.
Publicado: (2019)

Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
por: Yu, Xin, et al.
Publicado: (2018)

Extended lymphadenectomy for locally advanced and recurrent rectal cancer
por: Georgiou, Panagiotis A., et al.
Publicado: (2017)

Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study
por: Lin, Jun-Zhong, et al.
Publicado: (2016)

The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial
por: Hu, Yong-Hong, et al.
Publicado: (2018)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Song, Seung Ho, et al.
Publicado: (2021)

Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer
por: Verrijssen, An-Sofie E., et al.
Publicado: (2022)

Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
por: Solbakken, Arne M., et al.
Publicado: (2023)

Clinical predictors of pathological good response in locally advanced rectal cancer
por: Shao, Kongfeng, et al.
Publicado: (2021)

Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients
por: Zhang, Rong-xin, et al.
Publicado: (2017)

Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery
por: Rayan, Amal, et al.
Publicado: (2023)

Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer
por: Deng, Yu-Xiang, et al.
Publicado: (2017)

Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy
por: Ma, Wen-juan, et al.
Publicado: (2018)

Prognostic Value of the Cycle Number of Perioperative Chemotherapy in Locoregionally Advanced Rectal Cancer: a Propensity Score Matching Analysis
por: Chang, Hui, et al.
Publicado: (2018)

Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer
por: Liu, Zhenyu, et al.
Publicado: (2020)

Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer
Publicado: (2019)

Factors associated with metachronous metastases and survival in locally advanced and recurrent rectal cancer
por: Baird, D. L. H., et al.
Publicado: (2020)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
por: Ott, Oliver J., et al.
Publicado: (2021)

Surgical Management of Locally Recurrent Rectal Cancer
por: Hogan, Niamh M., et al.
Publicado: (2012)

Effect of understaging on local recurrence of rectal cancer
por: Giesen, Louis J. X., et al.
Publicado: (2020)

MRI-Based Radiomics Features to Predict Treatment Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer: A Single Center, Prospective Study
por: Chen, Bi-Yun, et al.
Publicado: (2022)

Advances in the treatment of locally advanced rectal cancer
por: Ali, Fadwa, et al.
Publicado: (2020)

Advances in surgery for locally advanced rectal cancer
por: Oh, Bo Young
Publicado: (2022)

Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
por: Peng, Hai-Hua, et al.
Publicado: (2013)

Neoadjuvant chemotherapy without radiation as a potential alternative treatment for locally advanced rectal cancer: A meta-analysis
por: Wu, Pei, et al.
Publicado: (2021)

Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial
por: Liu, Shuang, et al.
Publicado: (2023)

Impact factors of lymph node retrieval on survival in locally advanced rectal cancer with neoadjuvant therapy
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome
por: Niu, Shao-Qing, et al.
Publicado: (2021)

Preliminary Outcome of Individualized Abdominoperineal Excision for Locally Advanced Low Rectal Cancer
por: Zheng, Yi, et al.
Publicado: (2018)

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
por: Okamura, Ryosuke, et al.
Publicado: (2023)

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
por: Lindenberg, Melanie, et al.
Publicado: (2022)

Towards Standardisation of Technique for En Bloc Sacrectomy for Locally Advanced and Recurrent Rectal Cancer
por: Rogers, Ailín C., et al.
Publicado: (2021)

Transanal total mesorectal excision for locally advanced middle–low rectal cancers
por: Thien, H. H., et al.
Publicado: (2019)

High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer
por: Wang, Qiao-Xuan, et al.
Publicado: (2022)

Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
por: Lee, Joo Ho, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tdkiv4bet9bgj0ma5tq6ov1u9p